1. Brief Report: Remission Rates With Tofacitinib Treatment in Rheumatoid Arthritis: A Comparison of Various Remission Criteria. Issue 4 (8th March 2017) Authors: Smolen, Josef S.; Aletaha, Daniel; Gruben, David; Zwillich, Samuel H.; Krishnaswami, Sriram; Mebus, Charles Journal: Arthritis & rheumatology Issue: Volume 69:Issue 4(2017) Page Start: 728 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Improved disease activity with fosdagrocorat (PF‐04171327), a partial agonist of the glucocorticoid receptor, in patients with rheumatoid arthritis: a Phase 2 randomized study. (22nd March 2017) Authors: Stock, Thomas; Fleishaker, Dona; Wang, Xin; Mukherjee, Arnab; Mebus, Charles Journal: International journal of rheumatic diseases Issue: Volume 20:Number 8(2017) Page Start: 960 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The effect of tofacitinib on pneumococcal and influenza vaccine responses in rheumatoid arthritis. Issue 4 (20th March 2015) Authors: Winthrop, Kevin L; Silverfield, Joel; Racewicz, Arthur; Neal, Jeffrey; Lee, Eun Bong; Hrycaj, Pawel; Gomez-Reino, Juan; Soma, Koshika; Mebus, Charles; Wilkinson, Bethanie; Hodge, Jennifer; Fan, Haiyun; Wang, Tao; Bingham, Clifton O Journal: Annals of the rheumatic diseases Issue: Volume 75:Issue 4(2016) Page Start: 687 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗